Pierre Corbeau - Concepedia

Author

Pierre Corbeau

Centre National de la Recherche Scientifique ORCID

Also Known As

Corbeau, P., P CORBEAU, P Corbeau, P. Corbeau, PIERRE CORBEAU, Pierre Corbeau

135

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

Centre National de la Recherche Scientifique Institut de Génétique Humaine Inserm Université de Montpellier Hôpital Saint Eloi

About

Pierre Corbeau is an author at Centre National de la Recherche Scientifique specializing in medicine, immunology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	32	1.3K
2	Natural Sciences	2	2	116
3	Allergy	2	2	41
4	Engineering	1	1	33
5	Biochemistry	1	1	31

Pierre Corbeau

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Suppression of MicroRNA-Silencing Pathway by HIV-1 During Virus Replication Robinson Triboulet, Bernard Mari, Yea‐Lih Lin, Science	2007	624
Suv39H1 and HP1γ are responsible for chromatin‐mediated HIV‐1 transcriptional silencing and post‐integration latency Isaure du Chéné, Eugénia Basyuk, Yea‐Lih Lin, The EMBO Journal	2007	305
T cell apoptosis characterizes severe Covid-19 disease Sónia André, Morgane Picard, Renaud Cezar, Cell Death and Differentiation	2022	184
CD4<sup>+</sup>T Cell Surface CCR5 Density as a Determining Factor of Virus Load in Persons Infected with Human Immunodeficiency Virus Type 1 Jacques Reynes, Pierre Portalès, Michel Segondy, The Journal of Infectious Diseases ImmunodeficienciesImmunologyPathologyCd4 T Cell ResponsesImmune System	2000	175
Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study A. Jeandrot, J L Richard, Christophe Combescure, Diabetologia InflammationC-reactive Protein ConcentrationsAutoimmune DiseaseDiabetesLower Extremity Wound	2007	157
Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection Yea‐Lih Lin, Clément Mettling, Pierre Portalès, Proceedings of the National Academy of Sciences	2002	115
Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study Michèlle Rosenzwajg, Randa Salet, Roberta Lorenzon, Diabetologia Dose-finding StudyType 1Diabetes ManagementDiabetesClinical Trials	2020	98
CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression Jacques Reynes, Pierre Portalès, Michel Segondy, AIDS	2001	96
Small-Molecule Inhibition of HIV pre-mRNA Splicing as a Novel Antiretroviral Therapy to Overcome Drug Resistance Nadia Bakkour, Yea‐Lih Lin, Sophie Maire, PLoS Pathogens Rna SplicingImmunologyMolecular BiologyAntiviral DrugIndole Derivative	2007	85
An antibody that binds the immunoglobulin CDR3-like region of the CD4 molecule inhibits provirus transcription in HIV-infected T cells. Monsef Benkirane, Pierre Corbeau, V. Housset, The EMBO Journal Cd4 Molecule InhibitsHiv-infected T CellsHuman RetrovirusImmunologyAntiviral Response	1993	69

Page 1